Cargando…
The Evolution of Biomarkers in Thyroid Cancer—From Mass Screening to a Personalized Biosignature
Thyroid cancer is the most common malignancy of the endocrine system. The diagnosis of thyroid nodules, made by neck examination and ultrasonography, is a common event occurring in over 50% of the patient population over the age of 50. Yet, only 5% of these patients will be diagnosed with cancer. Fi...
Autores principales: | Grogan, Raymon H., Mitmaker, Elliot J., Clark, Orlo H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835110/ https://www.ncbi.nlm.nih.gov/pubmed/24281099 http://dx.doi.org/10.3390/cancers2020885 |
Ejemplares similares
-
Primary Hyperparathyroidism Patients with Positive Preoperative Sestamibi Scan and Negative Ultrasound Are More Likely to Have Posteriorly Located Upper Gland Adenomas (PLUGs)
por: Harari, Avital, et al.
Publicado: (2011) -
Controversies in the Management of Papillary Thyroid Cancer Revisited
por: Guerrero, Marlon A., et al.
Publicado: (2011) -
Identifying molecules as biosignatures with assembly theory and mass spectrometry
por: Marshall, Stuart M., et al.
Publicado: (2021) -
Exoplanet Biosignatures: Understanding Oxygen as a Biosignature in the Context of Its Environment
por: Meadows, Victoria S., et al.
Publicado: (2018) -
Metabolic Processes Preserved as Biosignatures in Iron-Oxidizing Microorganisms: Implications for Biosignature Detection on Mars
por: Floyd, Melissa A. Merrill, et al.
Publicado: (2019)